Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSUNRISE: Infliximab in Etanercept-Non-Responder Psoriasis
NCT00527072Phase 3Completed
- Sponsor
- Janssen Biotech
- Start
- Jul 2007
- Primary completion
- May 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in plaque psoriasis, sponsored by Janssen Biotech. Started Jul 2007; status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00527072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527072.